{"title":"偏头痛发作期间血浆血管性血友病因子水平","authors":"F. Öztürk, B. Oflazoğlu, H. Forta, Yeşim Bahadir","doi":"10.1163/156856906778026130","DOIUrl":null,"url":null,"abstract":"AbstractVon Willebrand factor (vWF) is produced in vascular endothelium where it is also released. It contributes to platelet aggregation and adhesion. We aimed to compare the vWF level in attack intervals of migraine patients with that of a control group. We measured the plasma vWF level in 25 patients and 25 healthy controls and we found no meaningful difference between the patients and the control group.","PeriodicalId":19808,"journal":{"name":"Pain Clinic","volume":"3 1","pages":"219-223"},"PeriodicalIF":0.0000,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plasma von Willebrand factor levels between migraine attacks\",\"authors\":\"F. Öztürk, B. Oflazoğlu, H. Forta, Yeşim Bahadir\",\"doi\":\"10.1163/156856906778026130\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AbstractVon Willebrand factor (vWF) is produced in vascular endothelium where it is also released. It contributes to platelet aggregation and adhesion. We aimed to compare the vWF level in attack intervals of migraine patients with that of a control group. We measured the plasma vWF level in 25 patients and 25 healthy controls and we found no meaningful difference between the patients and the control group.\",\"PeriodicalId\":19808,\"journal\":{\"name\":\"Pain Clinic\",\"volume\":\"3 1\",\"pages\":\"219-223\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pain Clinic\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1163/156856906778026130\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Clinic","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/156856906778026130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Plasma von Willebrand factor levels between migraine attacks
AbstractVon Willebrand factor (vWF) is produced in vascular endothelium where it is also released. It contributes to platelet aggregation and adhesion. We aimed to compare the vWF level in attack intervals of migraine patients with that of a control group. We measured the plasma vWF level in 25 patients and 25 healthy controls and we found no meaningful difference between the patients and the control group.